Close
Nordic 9Nordic 9

Fournier-Majoie (investor - Others)

Belgium fournier-majoie.org
See something wrong or missing? Let us know
Offices:Bruxelles

Fournier-Majoie Foundation is a non-profit organization whose mission is to identify, support and guide promising researchers.

Average round investment:5.56M USD
Average number per year:1.3
Distribution: 2026 (2)2024 (1)2021 (1)
Portfolio companies: Austria ValanxFrance Apmonia TherapeuticsFrance Hephaistos Pharma See the entire list
Mostly invests in: France France (3) Biotech (4)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Fournier-Majoie

Name Criteria
Italy Alchimia Investments
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States Lombardstreet Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom LongGame
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
France Circular Innovation Fund
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Germany Pace Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Austria
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Germany Think Health
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
France Anaxago
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
France Sofilaro
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
United States Climate Capital
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
United States Adjacent
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Top